CCKBR and hepatocellular carcinoma: Our research laboratory discovered that the cholecystokinin-B receptor (CCK-BR) is absent in normal liver tissue but becomes overexpressed in HCC, suggesting that this receptor may be an ideal target for the treatment of HCC [14].